Schedule 13G ownership disclosure
Integra LifeSciences Holdings Corp
Common Stock · CUSIP: 457985208
Event date: 2026-09-30
- Filing-level shares
- 4,164,366.00
- Percent of class
- 5.4%
- Invesco Ltd.
Shares: 4,164,366.00 · Class: 5.4%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0000914208-26-000418
- Form type
- SCHEDULE 13G
- Filer
- INTEGRA LIFESCIENCES HOLDINGS CORP
- CIK
- CIK 917520
- Filed
- Nov 10, 2026
- Reporting period
- Sep 30, 2026
- Description
- Schedule 13G beneficial ownership